Copy number aberration analysis to predict response to neoadjuvant anti-HER2 therapy: Results from the NeoALTTO phase III trial Meeting Abstract


Authors: Sotiriou, C.; Rothé, F.; Maetens, M.; Fumagalli, D.; Brown, D. N.; Salgado, R.; Bradbury, I.; Pusztai, L.; Harbeck, N.; Ignatiadis, M.; Sarp, S.; de la Pena, L.; de Azambuja, E.; Huober, J.; Nuciforo, P.; Baselga, J.; Piccart, M.; Loi, S.; Venet, D.
Abstract Title: Copy number aberration analysis to predict response to neoadjuvant anti-HER2 therapy: Results from the NeoALTTO phase III trial
Meeting Title: 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017)
Journal Title: Cancer Research
Volume: 78
Issue: 4 Suppl.
Meeting Dates: 2017 Dec 5-9
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2018-02-01
Language: English
ACCESSION: WOS:000425489400005
PROVIDER: wos
DOI: 10.1158/1538-7445.SABCS17-GS1-04
Notes: Meeting Abstract: GS1-04 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga